Details for New Drug Application (NDA): 217665
✉ Email this page to a colleague
NDA 217665 describes METRONIDAZOLE IN PLASTIC CONTAINER, which is a drug marketed by Amneal, Baxter Hlthcare Corp, Gland Pharma Ltd, Hospira, Inforlife, and Rising, and is included in six NDAs. It is available from six suppliers. Additional details are available on the METRONIDAZOLE IN PLASTIC CONTAINER profile page.
The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
The generic ingredient in METRONIDAZOLE IN PLASTIC CONTAINER is metronidazole. There are eighteen drug master file entries for this compound. Seventy-three suppliers are listed for this compound. Additional details are available on the metronidazole profile page.
Summary for 217665
| Tradename: | METRONIDAZOLE IN PLASTIC CONTAINER |
| Applicant: | Amneal |
| Ingredient: | metronidazole |
| Patents: | 0 |
Suppliers and Packaging for NDA: 217665
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| METRONIDAZOLE IN PLASTIC CONTAINER | metronidazole | INJECTABLE;INJECTION | 217665 | ANDA | Amneal Pharmaceuticals Private Limited | 80830-2465 | 80830-2465-9 | 24 POUCH in 1 CARTON (80830-2465-9) / 1 BAG in 1 POUCH (80830-2465-1) / 100 mL in 1 BAG |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 500MG/100ML | ||||
| Approval Date: | May 24, 2023 | TE: | AP | RLD: | No | ||||
Complete Access Available with Subscription
